Eagle Bay Advisors LLC
- SEC CIK
- 0001862864
- Latest filing
- Aug 3, 2026
CHRS holding history
Coherus Oncology, Inc. in every 13F filed by Eagle Bay Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −30−100.0% | Sold out | Holders |
| Q1 2024 | 30 | $72 | <0.1% | −39−56.5% | Reduced | Holders |
| Q4 2023 | 69 | $230 | <0.1% | −5,164−98.7% | Reduced | Holders |
| Q3 2023 | 5,233 | $19.6K | <0.1% | +3,729+247.9% | Added | Holders |
| Q2 2023 | 1,504 | $6.42K | <0.1% | −2,732−64.5% | Reduced | Holders |
| Q1 2023 | 4,236 | $29.0K | <0.1% | +3,009+245.2% | Added | Holders |
| Q4 2022 | 1,227 | $9.72K | <0.1% | −2,775−69.3% | Reduced | Holders |
| Q3 2022 | 4,002 | $39.0K | <0.1% | +111+2.9% | Added | Holders |
| Q2 2022 | 3,891 | $28.2K | <0.1% | +2,243+136.1% | Added | Holders |
| Q1 2022 | 1,648 | $21.0K | <0.1% | −472−22.3% | Reduced | Holders |
| Q4 2021 | 2,120 | $34.0K | <0.1% | +354+20.0% | Added | Holders |
| Q3 2021 | 1,766 | $28.0K | <0.1% | −155−8.1% | Reduced | Holders |
| Q2 2021 | 1,921 | $28.0K | <0.1% | – | No prior filing | Holders |